Insight Holdings Group, LLC sold $10.2M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 142,311 indirectly-held shares of Hinge Health, Inc. (HNGE) at $71.67 ($10.20M total) across 2 trades on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 25, 2026, 1:57 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 25, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HNGE
Bearish
medium confidence
Mentioned
$HNGE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGEBearishLow
01

Why it matters

A 10% owner sold ~$10.2M of HNGE shares via open-market trades under a Rule 10b5-1 plan, leaving 0 shares after the transaction.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure reduces the immediacy of any negative fundamental inference.

03

What to watch

The filing does not reveal whether other insiders or the company have offsetting buys; also, indirect holdings may not map cleanly to near-term control or operating outlook.

Relevance 6/10Novelty 6/10Timing: filed after-hours on 2026-06-24; relevant for next session positioning

Background

The article is an SEC Form 4 insider transaction disclosure for Hinge Health, Inc. (HNGE).

Company-level read

Ticker impact

$HNGEBearishMedium confidence
Context

SEC Form 4 shows Insight Holdings Group, LLC (10% owner) sold 142,311 HNGE shares in open-market trades at ~$71.67.

Expected impact

Near-term sentiment risk; likely limited fundamental impact unless follow-on selling continues.

Evidence & confidence

The filing is primary-source and sizable (~$10.2M), but it is a pre-arranged 10b5-1 plan, which typically lowers the signal strength versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio rebalancing rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider sale; 142,311 shares sold at ~$71.6669.

  • Insight Holdings Group, LLC

    10% owner who executed the open-market sale under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.